ETV Bharat / international
బుల్డాగ్ అందాల పోటీలో విజేత 'బ్యూ' - university
అందమైన బుల్డాగ్ను ఎంపిక చేసేందుకు అమెరికా డ్రేక్ విశ్వవిద్యాలయంలో ప్రతి ఏడాది ఓ పోటీని నిర్వహిస్తున్నారు. ఈ సంవత్సరం పోటీల్లో 'బ్యూ' అనే శునకరాజం విజయం సాధించింది.
డ్రేక్ విశ్వవిద్యాలయం మెచ్చిన శునకరాజం..
By
Published : Apr 24, 2019, 2:37 PM IST
డ్రేక్ విశ్వవిద్యాలయం మెచ్చిన శునకరాజం.. అమెరికాలోని డ్రేక్ విశ్వవిద్యాలయం ఏటా ఓ వింత పోటీ నిర్వహిస్తుంటుంది. ఆ పోటీలు ఏమిటనుకుంటున్నారు? అందమైన పోటీలు... ఇందులో వింతేముంది అంటారా... ఆ పోటీలు ఎవరికనుకుంటున్నారు? శునకాలకు.
డ్రేక్ విశ్వవిద్యాలయంలో ఏటా బుల్డాగ్లకు అందాల పోటీలు నిర్వహిస్తుంటారు. ఈ సంవత్సరం పోటీల్లో డెస్ మోనీస్ ప్రాంతానికి చెందిన 'బ్యూ' అనే శునకరాజం నేనే నంబర్ వన్ అంటూ ముందు నిలిచింది.
న్యాయనిర్ణేత నదియా వాలంటైన్... 'బ్యూ' తన అందమైన రూపంతో ఆకట్టుకునేలా ఉందని కితాబిచ్చారు. 3 వేల మంది వీక్షకుల మధ్య 'బ్యూ'కు కిరీటాన్ని ధరింపజేశారు నిర్వాహకులు.
ఈ శునకాల పోటీని డ్రేక్ విశ్వవిద్యాలయం నిర్వహించడం 40వ సారి.
ఇదీ చూడండి: గుర్దాస్పుర్ నుంచి లోక్సభ బరిలో సన్నీ
డ్రేక్ విశ్వవిద్యాలయం మెచ్చిన శునకరాజం.. అమెరికాలోని డ్రేక్ విశ్వవిద్యాలయం ఏటా ఓ వింత పోటీ నిర్వహిస్తుంటుంది. ఆ పోటీలు ఏమిటనుకుంటున్నారు? అందమైన పోటీలు... ఇందులో వింతేముంది అంటారా... ఆ పోటీలు ఎవరికనుకుంటున్నారు? శునకాలకు.
డ్రేక్ విశ్వవిద్యాలయంలో ఏటా బుల్డాగ్లకు అందాల పోటీలు నిర్వహిస్తుంటారు. ఈ సంవత్సరం పోటీల్లో డెస్ మోనీస్ ప్రాంతానికి చెందిన 'బ్యూ' అనే శునకరాజం నేనే నంబర్ వన్ అంటూ ముందు నిలిచింది.
న్యాయనిర్ణేత నదియా వాలంటైన్... 'బ్యూ' తన అందమైన రూపంతో ఆకట్టుకునేలా ఉందని కితాబిచ్చారు. 3 వేల మంది వీక్షకుల మధ్య 'బ్యూ'కు కిరీటాన్ని ధరింపజేశారు నిర్వాహకులు.
ఈ శునకాల పోటీని డ్రేక్ విశ్వవిద్యాలయం నిర్వహించడం 40వ సారి.
ఇదీ చూడండి: గుర్దాస్పుర్ నుంచి లోక్సభ బరిలో సన్నీ
RESTRICTION SUMMARY: AP CLIENTS ONLY
SHOTLIST:
UNTV - AP CLIENTS ONLY
Llilongwe, Malawi - 23 April 2019
1. Various of child receiving vaccine
UNTV - AP CLIENTS ONLY
Geneva - 23 April 2019
2. Mid of news conference
3. SOUNDBITE (English) Kate O'Brien, Director, Department of Immunization, Vaccines and Biologicals, World Health Organization (WHO):
"As much of a milestone as it is, it is an imperfect vaccine against a complex disease, but it's also a vaccine that has significant potential to save lives and deliver on the health aspirations that we have for all children around the world."
4. Mid of news conference
5. SOUNDBITE (English) Kate O'Brien, Director, Department of Immunization, Vaccines and Biologicals, World Health Organization (WHO):
"The anticipation is that there will be about 360,000 children each year who will be vaccinated across the three countries."
6. Mid of news conference
7. SOUNDBITE (English) Pedro Alonso, Director, Global Malaria Programme, World Health Organization (WHO):
"The question could be well, why not wait until we have something better. Well, and the answer to that is because we know we're dealing with a very, very hard organism and that's why I mentioned before this is the first vaccine against the human malaria parasite. Parasites are really complex organisms much more so than a virus or a bacteria. And that's why it has taken 30 years to develop this first vaccine."
8. Tilt up of journalist taking notes
9. SOUNDBITE (English) Pedro Alonso, Director, Global Malaria Programme, World Health Organization (WHO):
"I always remember when 30 years ago, we as many others were developing insecticide-treated bed nets, they were met with similar scepticism. 'Oh, they only prevented 40 percent of clinical malaria' - oddly enough the same level that this vaccine provides. And insecticide-treated bed nets were met with significant scepticism, but data showed that they could actually have a massive impact on mortality and as such they've become the cornerstone, the backbone of our malaria control efforts that have resulted in over 7 million deaths being averted."
UNTV - AP CLIENTS ONLY
Llilongwe, Malawi - 23 April 2019
10. Various of exterior of health centre ++MUTE++
11. Crowd waiting at health centre
12. SOUNDBITE (Chichewa) Alinafe Tsitsi, mother:
"My husband's illness from malaria prompted me to come here for the malaria vaccine, because I heard an announcement in my village that the hospital was vaccinating children against malaria. Malaria is a dangerous disease. When I saw how ill my husband was from malaria I was concerned that if my children got ill from malaria it would be much worse for them. I don't want my child to suffer from malaria, that is why my child is getting the malaria vaccine."
13. Various of health worker drawing vaccine
14. Tilt down, mother with baby
15. SOUNDBITE (English) Michael Kayange, deputy-director for malaria, Malawi Ministry of Health:
"Malaria is a huge public health problem in Malawi. We see about 6 million cases each year, and we register close to 3000 deaths each year. And per day, I would say we register about eight deaths every day. So, it's quite a huge problem, a public health problem in Malawi. And that's why this malaria vaccine which has potential to prevent some cases and also save some lives, as a country we're quite positive about it and they we're happy that we're introducing this vaccine."
16. Wide of people outside health centre ++MUTE++
17. Close of sleeping baby
STORYLINE:
The World Health Organization says Malawi has become the first country to begin immunising children against malaria, using the only licensed vaccine to protect against the mosquito-spread disease.
Although the vaccine only protects about one-third of children who are immunised, those who get the shots are likely to have less severe cases of malaria.
The parasitic disease kills about 435,000 people every year, the majority of them children under 5 in Africa.
The vaccine, known as Mosquirix, was developed by GlaxoSmithKline and was approved by the European Medicines Agency in 2015.
A previous trial showed the vaccine was about 30% effective in children who got four doses, but that protection waned over time.
Pedro Alonso, director of WHO's malaria program, said similar vaccination programs would begin in the coming weeks in Kenya and Ghana, with the aim of reaching about 360,000 children per year across the three countries.
Alonso called the vaccination rollout a "historical moment," noting that it was significantly more difficult to design a vaccine against a parasite as opposed to a bacterium or virus.
It took GSK and partners more than 30 years to develop the vaccine, at a cost of around $1 billion.
GSK is donating up to 10 million vaccine doses in the current vaccination initiatives.
A company spokesman said GSK is working with partners to secure funding for potentially broader vaccination programs.
Some experts warned the vaccination programs should not divert limited public health funds from inexpensive and proven tools to curb malaria such as bed nets and insecticides.
===========================================================
Clients are reminded:
(i) to check the terms of their licence agreements for use of content outside news programming and that further advice and assistance can be obtained from the AP Archive on: Tel +44 (0) 20 7482 7482 Email: info@aparchive.com
(ii) they should check with the applicable collecting society in their Territory regarding the clearance of any sound recording or performance included within the AP Television News service
(iii) they have editorial responsibility for the use of all and any content included within the AP Television News service and for libel, privacy, compliance and third party rights applicable to their Territory.
